Effectiveness and Safety of Treating Negative Emotions after PCI from the Perspective of Qi and Blood: A Systematic Review and Meta-Analysis

Table 1

Basic characteristics of the included studies.

Study	Year	Sample size (T/C)	Mean age (years, )		Interventions		Treatment (weeks)	Ending indicators
			T	C	T	C
Cong [11]	2020	72 (36/36)	NA	NA	Yangxin decoction	Deanxit	4	①②③
Ding [12]	2020	60 (30/30)	52.43 ± 7.74	54.76 ± 9.20	Baihetiaolv decoction	Deanxit	4	①②
Lu [13]	2019	79 (38/41)	64.13 ± 6.72	63.12 ± 7.55	Jieyushugantongmai decoction	Deanxit	2	③④
Qi [14]	2017	90 (45/45)	51 ± 9.4	54 ± 10.6	Jieyutongmai granules	Deanxit	2	②
Liang [15]	2015	300 (149/151)	76 ± 4	77 ± 5	Shuganjieyu decoction	Deanxit	6	①④
Ye et al. [16]	2012	78 (39/39)	67.0 ± 8.0	68.0 ± 7.0	Shuganjieyu capsules	Paroxetine	6	①②③④
Liu et al. [17]	2019	80 (40/40)	48.45 ± 10.35	48.22 ± 11.23	Yuzheng decoction	Deanxit	2	①④
Liu [18]	2015	183 (92/91)	NA	NA	Yuzheng decoction	Deanxit	8	①
Wang [19]	2016	60 (30/30)	NA	NA	Chaihushugan decoction	Deanxit	14	③
Rong [20]	2020	60 (30/30)	55.10 ± 7.59	56.47 ± 6.32	Chaihuwendan decoction	Deanxit	4	①②
Zhang [21]	2020	60 (30/30)	57.86 ± 8.07	57.31 ± 7.63	Chaiguilongmu decoction	Deanxit	4	①②④
Zhao [22]	2018	64 (32/32)	60.22 ± 5.96	56.88 ± 7.25	Shuganjieyutongmai decoction	Escitalopram	16	①③⑤
Shi [23]	2016	68 (34/34)		58.55 ± 1.52	Jieyutongmai decoction	Escitalopram	8	③④⑤
Sun [24]	2012	60 (30/30)	58.2	56.1	Jieyutongbi decoction	Escitalopram	6	③④

Notes: T, intervention groups; C, control groups; NA, did not mention; ① efficacy of TCM evidence; ② HAMA pre- and posttreatment score reduction efficiency; ③ HAMD pre- and posttreatment score reduction efficiency; ④ incidence of adverse events; and ⑤ SAQ.